Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003128941 | SCV003805290 | pathogenic | not provided | 2022-08-14 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31625560, 29036646, 35451537) |
Prevention |
RCV003410266 | SCV004108154 | pathogenic | PBX1-related disorder | 2023-05-26 | criteria provided, single submitter | clinical testing | The PBX1 c.862C>T variant is predicted to result in premature protein termination (p.Arg288*). This variant was reported as a de novo finding in an individual with PBX1-related congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay (Slavotinek et al. 2017. PubMed ID: 29036646). This variant is reported in 0.0065% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-164781251-C-T). Nonsense variants in PBX1 are expected to be pathogenic. This variant is interpreted as pathogenic. |
Equipe Genetique des Anomalies du Developpement, |
RCV004017970 | SCV004847245 | pathogenic | Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | 2023-11-09 | criteria provided, single submitter | clinical testing |